The WuXi acquisition of Apptec (posted last week) is continuing the trend of consolidation in the cell manufacturing sector. It is similar to Lonza’s (a Swiss company) purchase of Cambrex’s biologics division in 2006, and GE’s purchase of Wave Biotech in mid-2007. Lonza is currently the largest manufacturer of cells for therapy, and has process development and manufacturing relationships with many of today’s clinical-stage regenerative medicine companies. GE is making a big splash with a heavy marketing campaign for the Wave bioproduction system and states in the acquisition press release that “Wave Biotech’s single use bioreactors are increasingly being used to enable the manufacture of patient-specific cell and gene therapy products.” GE is no dummy when it comes to acquiring growth companies and it has increasingly moved to a service-based business in the last 10 years. Now that Stem Cells Inc. is planning to purchase Progenitor Cell Therapy, it looks like Cognate Bioservices is the last ‘major’ cell therapy manufacturer still on it’s own.
Blogroll
- Ben’s Stem Cell News
- Biosingularity
- Biotech Blog
- Cell WISE
- CellTherapyBlog
- CellTherapyNews
- Fierce Biotech
- Fredrick County, MD Biotech Community
- Hematopoiesis
- IN VIVO blog
- Life Sciences Chronicle
- List of Biotech Conferences
- My Biotech Life
- Partial Immortalization
- Stem Cell Patents
- The Niche
- The Stem Cell
- US PTO
- Venture Beat – Lifesciences
- Wired Blogs – Science
- WordPress.com
Cool Regenmed Jobs
- Biomaterials and Diabetes Scientists at Living Cell Technologies (New Zealand)
- Cell and Tissue Culture Technicians at Pharmacell (ex-US)
- Cell Culture, Bioprocess, Analytical, and Tissue Engineering positions open at Tengion
- Cell Process Development and Production Positions at Cognate Bioservices
- Cell Therapy Business Development Leader at Invitrogen
- Jobs at Geron: chemists, process and product development, cell biology, immunology, assay development, and quality positions
- Manufacturing Manager at Cognate Bioservices
- Process Dev, R&D, Quality and other jobs at Tigenix (Belgium and US)
- RegenMed Scientists and Research Associates at Athersys
- Research and Quality positions at Biomimetic Therapeutics
General Science
Local Biotech Gateways
Other Biotech Blogs
Patents
Archives
Catagory Cloud
adult stem cell Advanced Cell Technology Apptec Athersys BD Big Pharma Biomaterials Bioprocessing business models cardiac regeneration cell delivery Clinical Trials combination products Company Profiles Embyonic Stem Cells FDA Geron Innovation Intellectual Property Invitrogen JNJ Job search Joint Ventures Manufacturing Novocell Osiris Regenerative Medicine regulatory stem cells vascular regeneration
The Regeneration Station 
Jon,
Rumor has it ( actually, substantiated rumor), that Lonza is going to sink another $25 to $35MM into their Cell Therapy business here in Frederick County (Walkersville). A lot of that is funded by their contract manufacturing of Osiris’ products.
If you’d like to check it out, another “Gateway” blog is going on in Colorado called the Colorado Life Science Deal flow @ http://www.rnaventures.blogspot.com/